Enhanced antitumor immunity is elicited by adenovirus-mediated gene transfer of CCL21 and IL-15 in murine colon carcinomas

Cellular Immunology

Volumn 289, Issue 1-2, 2014, Pages 155-161

  Zhao, Dong xu ^a   Li, Zhi jie ^b   Zhang, Yang ^d   Zhang, Xiao na ^d   Zhao, Kun chi ^a   Li, Ya gang ^c   Zhang, Meng meng ^c   Yu, Xiao wei ^d   Liu, Ming yuan ^a,e   Li, Yang ^a  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^b INSTITUTE OF PLANT PROTECTION   (China)

^c PR China   (China)

^d JILIN UNIVERSITY   (China)

^e YANGZHOU UNIVERSITY   (China)

Author keywords

Bicistronic adenovirus; Cancer immunotherapy; CCL21; Chemokines; IL 15

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 15; SECONDARY LYMPHOID TISSUE CHEMOKINE;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNIZATION; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CANCER THERAPY; CELL PROTECTION; CELL VIABILITY; CHEMOTAXIS; COLON CARCINOMA; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; TUMOR IMMUNITY; VIRAL GENE DELIVERY SYSTEM;

BICISTRONIC ADENOVIRUS; CANCER IMMUNOTHERAPY; CCL21; CHEMOKINES; IL-15;

3T3 CELLS; ADENOVIRIDAE; ANIMALS; CANCER VACCINES; CELL LINE, TUMOR; CELL MOVEMENT; CHEMOKINE CCL21; COLONIC NEOPLASMS; DENDRITIC CELLS; GENE TRANSFER TECHNIQUES; GENETIC THERAPY; HUMANS; IMMUNOTHERAPY; INTERLEUKIN-15; MICE; T-LYMPHOCYTES, CYTOTOXIC;

EID: 84900798699     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2014.03.020     Document Type: Article

References (40)

1. Shrikant P., Mescher M.F. Opposing effects of IL-2 in tumor immunotherapy: promoting CD8 T cell growth and inducing apoptosis. J. Immunol. 2002, 169:1753-1759.
2. He Y.F., Wang X.H., Zhang G.M., Chen H.T., Zhang H., Feng Z.H. Sustained low-level expression of interferon-gamma promotes tumor development: potential insights in tumor prevention and tumor immunotherapy. Cancer Immunol. Immunother. 2005, 54:891-897.
3. Jin H.T., Youn J.I., Kim H.J., Lee J.B., Ha S.J., Koh J.S., et al. Enhancement of interleukin-12 gene-based tumor immunotherapy by the reduced secretion of p40 subunit and the combination with farnesyltransferase inhibitor. Hum. Gene Ther. 2005, 16:328-338.
4. Fossa S.D., Martinelli G., Otto U., Schneider G., Wander H., Oberling F., et al. Recombinant interferon alfa-2a with or without vinblastin in metastatic renal cell carcinoma: results of a European multi-center phase III study. Ann. Oncol. 1992, 3:301-305.
5. Sedlar A., Kranjc S., Dolinsek T., Cemazar M., Coer A., Sersa G. Radiosensitizing effect of intratumoral interleukin-12 gene electrotransfer in murine sarcoma. BMC Cancer 2013, 13:38.
6. Kuppala M.B., Syed S.B., Bandaru S., Varre S., Akka J., Mundulru H.P. Immunotherapeutic approach for better management of cancer-role of IL-18. Asian Pac. J. Cancer Prev. 2012, 13:5353-5361.
7. Quezada S.A., Peggs K.S., Simpson T.R., Allison J.P. Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication. Immunol. Rev. 2011, 241:104-118.
8. Xin H., Kikuchi T., Andarini S., Ohkouchi S., Suzuki T., Nukiwa T., et al. Antitumor immune response by CX3CL1 fractalkine gene transfer depends on both NK and T cells. Eur. J. Immunol. 2005, 35:1371-1380.
9. Yan L., Anderson G.M., DeWitte M., Nakada M.T. Therapeutic potential of cytokine and chemokine antagonists in cancer therapy. Eur. J. Cancer 2006, 42:793-802.
10. Amedei A., Prisco D., D' Elios M.M. The use of cytokines and chemokines in the cancer immunotherapy. Recent Pat. Anticancer Drug Discovery 2013, 8:126-142.
11. Chada S., Ramesh R., Mhashilkar A.M. Cytokine- and chemokine-based gene therapy for cancer. Curr. Opin. Mol. Ther. 2003, 5:463-474.
12. Mulligan A.M., Raitman I., Feeley L., Pinnaduwage D., Nguyen L.T., O'Malley F.P., et al. Tumoral lymphocytic infiltration and expression of the chemokine CXCL10 in breast cancers from the Ontario Familial Breast Cancer Registry. Clin. Cancer Res. 2013, 19:336-346.
13. Franciszkiewicz K., Boissonnas A., Boutet M., Combadière C., Mami-Chouaib F. Role of chemokines and chemokine receptors in shaping the effector phase of the antitumor immune response. Cancer Res. 2012, 72:6325-6332.
14. Dayanidhi R., Paige J.B., Yee M.T., Ann R. Role of chemokines in tumor growth. Cancer Lett. 2007, 256:137-165.
15. Guo J., Wang B., Zhang M., Chen T., Yu Y., Regulier E., et al. Macrophage-derived chemokine transfer results in tumor regression in murine lung carcinoma model through efficient induction of antitumor immunity. Gene Ther. 2002, 9:793-803.
16. Schroers R., Davis C.M., Wanger H.J., Chen S.Y. Lentiviral transduction of human T-lymphocytes with a RANTES intrakine inhibits human immunodeficiency virus type 1 infection. Gene Ther. 2000, 9:889-897.
17. Xia D.J., Zhang W.P., Zheng S., Wang J., Pan J.P., Wang Q., et al. Lymphotactin cotransfection enhances the therapeutic efficacy of dendritic cells genetically modified with melanoma antigen gp100. Gene Ther. 2002, 9:592-601.
18. Yang S.C., Batra R.K., Hillinger S., Reckamp K.L., Strieter R.M., Dubinett S.M., et al. Intrapulmonary administration of CCL21 gene-modified dendritic cells reduces tumor burden in spontaneous murine bronchoalveolar cell carcinoma. Cancer Res. 2006, 15:3205-3213.
19. Yang S.C., Hillinger S., Riedl K., Zhang L., Zhu L., Huang M., et al. Intratumoral administration of dendritic cells overexpressing CCL21 generates systemic antitumor responses and confers tumor immunity. Clin. Cancer Res. 2004, 15:2891-2901.
20. Katsuyoshi F., Luis S., Edgar G.E., Miriam M. Induction of potent antitumor immunity by in situ targeting of intratumoral DCs. J. Clin. Invest. 2004, 113:774-783.
21. Turner J.E., Paust H.J., Steinmetz O.M., Peters A., Riedel J.H., Erhardt A., et al. CCR6 recruits regulatory T cells and Th17 cells to the kidney in glomerulonephritis. J. Am. Soc. Nephrol. 2012, 21:974-985.
22. Christensen U., Haagerup A., Binderup H.G., Vestbo J., Kruse T.A., Børglum A.D. Family based association analysis of the IL2 and IL15 genes in allergic disorders. Eur. J. Hum. Genet. 2006, 14:227-235.
23. Meazza R., Lollini P.L., Nanni P., De Giovanni C., Gaggero A., Comes A., et al. Gene transfer of a secretable form of IL-15 in murine adenocarcinoma cells: effects on tumorigenicity, metastatic potential and immune response. Int. J. Cancer 2000, 87:574-581.
24. Di C.E., Comes A., Basso S., De Ambrosis A., Meazza R., Musiani P., et al. The combined action of IL-15 and IL-12 gene transfer can induce tumor cell rejection without T and NK cell involvement. J. Immunol. 2000, 165:3111-3118.
25. Cao S., Troutt A.B., Rustum Y.M. Interleukin 15 protects against toxicity and potentiates antitumor activity of 5-fluorouracil alone and in combination with leucovorin in rats bearing colorectal cancer. Cancer Res. 1998, 58:1695-1699.
26. Ngoi S.M., Chien A.C., Lee C.G. Exploiting internal ribosome entry sites in gene therapy vector design. Curr. Gene Ther. 2004, 4:15-31.
27. Zhu Y., Lv H., Xie Y., Sheng W., Xiang J., Yang J. Enhanced tumor suppression by an ING4/IL-24 bicistronic adenovirus-mediated gene cotransfer in human non-small cell lung cancer cells. Cancer Gene Ther. 2011, 18:627-636.
28. Kuate S., Stefanou D., Hoffmann D., Wildner O., Uberla K. Production of lentiviral vectors by transient expression of minimal packaging genes from recombinant adenoviruses. J. Gene Med. 2004, 6:1197-1205.
29. Ding Z., Li Z.J., Zhang X.D., Li Y.G., Liu C.J., Li Y., et al. Proteomic alteration of Marc-145 cells and PAMs after infection by porcine reproductive and respiratory syndrome virus. Vet. Immunol. Immunopathol. 2012, 145:206-213.
30. Li Y., Liu Y.H., Li Z.J., Liu M.Y., Li Y.G., Jin H., et al. Staphylococcus aureus infection of intestinal epithelial cells induces human umbilical cord-derived mesenchymal stem cell migration. Int. Immunopharmacol. 2013, 15:176-181.
31. Li Y., Liu Y.H., Li Z.J., Li Y.G., Liu M.Y., Liu L.B., Wang X.G., et al. Identification and characterization of antigenic epitope of Staphylococcus aureus ClfA adhesin. Res. Vet. Sci. 2013, 94:490-495.
32. Kim T.Y., Myoung H.J., Kim J.H., Moon I.S., Kim T.G., Ahn W.S., et al. Both E7 and CpG-oligodeoxynucleotide are required for protective immunity against challenge with human papillomavirus 16 (E6/E7) immortalized tumor cells: involvement of CD4+ and CD8+ T cells in protection. Cancer Res. 2002, 62:7234-7240.
33. Baekkevold E.S., Yamanaka T., Palframan R.T., Carlsen H.S., Reinholt F.P., von Andrian U.H., et al. The CCR7 ligand ELC (CCL19) is transcytosed in high endothelial venules and mediates T cell recruitment. J. Exp. Med. 2001, 193:1105-1112.
34. Yanagawa Y., Onoe K. CCR7 ligands induce rapid endocytosis in mature dendritic cells with concomitant up-regulation of Cdc42 and Rac activities. Blood 2003, 101:4923-4929.
35. Wu S., Xing W., Peng J., Yuan X., Zhao X., Lei P., et al. Tumor transfected with CCL21 enhanced reactivity and apoptosis resistance of human monocyte-derived dendritic cells. Immunobiology 2008, 213:417-426.
36. Zimmermann V.S., Bondanza A., Monno A., Rovere-Querini P., Corti A., Manfredi A.A. TNF-alpha coupled to membrane of apoptotic cells favors the cross-priming to melanoma antigens. J. Immunol. 2004, 172:2643-2650.
37. Gavin P.C.M., Robert D.S. Interferons, immunity and cancer immunoediting. Nat. Immunol. 2006, 6:836-848.
38. Veckman V., Osterlund P., Fagerlund R., Melen K., Matikainen S., Julkunen I. TNF-alpha and IFN-alpha enhance influenza-A-virus-induced chemokine gene expression in human A549 lung epithelial cells. Virology 2006, 345:96-104.
39. Belardelli F., Ferrantini M. Cytokines as a link between innate and adaptive antitumor immunity. Trends Immunol. 2002, 23:201-208.
40. Fushimi T., Kojima A., Moore M.A., Crystal R.G. Macrophage inflammatory protein 3alpha transgene attracts dendritic cells to established murine tumors and suppresses tumor growth. J. Clin. Invest. 2000, 105:1383-1393.